Skip to main content

Table 5 Cost, incremental cost and impact of screening strategies

From: Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations

 

Targeted screening

Universal

 

≥ age 50†

≥ age 45

≥ age 40

≥ age 35

screening

Overall

     

Estimated cost to detect 1 high risk individual, MYR (USD)

92.64 (29.73)

110.08 (35.33)

131.51 (42.20)

158.13 (50.75)

187.2 (60.08)

Incremental cost per additional high risk individual detected, MYR

-

490.27

2060.12

15483.29

358444.85

(USD)

-

(157.34)

(661.14)

(4968.96)

(115033.65)

NNS to prevent one CV event

62.24

76.14

96.64

123.95

146.73

NNS to prevent one CV event (sensitivity analyses)

168.47

206.07

261.57

335.48

397.15

Males

     

Estimated cost to detect 1 high risk individual, MYR (USD)

69.05 (22.16)

82.64 (26.52)

99.44 (31.91)

121.01 (38.84)

144.13 (46.25)

Incremental cost per additional high risk individual detected, MYR

-

306.21

1180.58

8825.99

258952.77

(USD)

-

(98.27)

(378.88)

(2832.47)

(83104.23)

NNS to prevent one CV event

45.33

57.27

72.96

94.33

112.36

NNS to prevent one CV event (sensitivity analyses)

120.13

151.77

193.36

249.97

297.77

Females

     

Estimated cost to detect 1 high risk individual, MYR (USD)

133.01 (42.69)

158.88 (50.99)

189.18 (60.71)

225.02 (72.21)

264.83 (84.99)

Incremental cost per additional high risk individual detected, MYR

-

1426.50

8669.32

76295.96

293818.47

(USD)

-

(457.8)

(2782.19)

(24485.23)

(94293.47)

NNS to prevent one CV event

85.72

105.59

129.78

165.01

194.20

NNS to prevent one CV event (sensitivity analyses)

240.97

394.25

364.83

463.95

545.95

  1. CV cardiovascular, NNS numbers needed to screen.
  2. MYR Malaysian Ringgit, USD US Dollar. 1.00 USD = 3.11600 MYR.
  3. * for incremental costs, reference screening strategy is directly to the left of screening strategy assessed.
  4. † first reference group (for ages ≥ 45).